The association between inflammation and glucose levels in hospitalised patients with type 2 diabetes

Documenti analoghi

• Most hospitalised patients with type 2 diabetes benefit from continuous glucose monitoring compared to point‐of‐care glucose testing in a non‐intensive care unit setting: A heterogeneity of treatment effect analysis
  di: Mikkel Thor Olsen, et al.
  Pubblicazione: (2025)
• Satisfaction with continuous glucose monitoring and diabetes care among hospitalised patients with type 2 diabetes managed by inpatient diabetes teams
  di: Mikkel Thor Olsen, et al.
  Pubblicazione: (2025)
• Effects of Continuous Versus Intermittent Glucose Monitoring in Intensive Care Unit Patients: A Systematic Review With Meta‐Analysis
  di: Christian Lange Gantzel, et al.
  Pubblicazione: (2026)
• Faster‐acting insulin aspart versus insulin aspart for adults with type 1 diabetes treated with non‐automated insulin pump and continuous glucose monitoring—A double‐blind randomized controlled crossover trial
  di: Ajenthen G. Ranjan, et al.
  Pubblicazione: (2025)
• Glucagon‐like‐peptide‐1 receptor agonists versus dipeptidyl peptidase‐4 inhibitors and cardiovascular outcomes in diabetes in relation to achieved glycemic control. A Danish nationwide study
  di: Bochra Zareini, et al.
  Pubblicazione: (2024)